184 related articles for article (PubMed ID: 15474722)
1. Intranasal immunisation against tetanus with an attenuated Bordetella bronchiseptica vector expressing FrgC: improved immunogenicity using a Bvg-regulated promoter to express FrgC.
Stevenson A; Roberts M
Vaccine; 2004 Oct; 22(31-32):4300-5. PubMed ID: 15474722
[TBL] [Abstract][Full Text] [Related]
2. Use of a rationally attenuated Bordetella bronchiseptica as a live mucosal vaccine and vector for heterologous antigens.
Stevenson A; Roberts M
Vaccine; 2002 May; 20(17-18):2325-35. PubMed ID: 12009288
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, heat stability and safety of intranasally administered Bacillus subtilis spore or vegetative cell vaccines expressing tetanus toxin fragment C.
Lee S; Belitsky BR; Brown DW; Brinker JP; Kerstein KO; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
Vaccine; 2010 Sep; 28(41):6658-65. PubMed ID: 20709005
[TBL] [Abstract][Full Text] [Related]
4. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.
Roberts M; Bacon A; Li J; Chatfield S
Infect Immun; 1999 Aug; 67(8):3810-5. PubMed ID: 10417142
[TBL] [Abstract][Full Text] [Related]
5. Oral vaccination of mice against tetanus with recombinant Lactococcus lactis.
Robinson K; Chamberlain LM; Schofield KM; Wells JM; Le Page RW
Nat Biotechnol; 1997 Jul; 15(7):653-7. PubMed ID: 9219268
[TBL] [Abstract][Full Text] [Related]
6. Reduction of the ganglioside binding activity of the tetanus toxin HC fragment destroys immunogenicity: implications for development of novel tetanus vaccines.
Qazi O; Sesardic D; Tierney R; Söderbäck Z; Crane D; Bolgiano B; Fairweather N
Infect Immun; 2006 Aug; 74(8):4884-91. PubMed ID: 16861677
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of tetanus toxin fragment C in Escherichia coli with thioredoxin and its evaluation as an effective subunit vaccine candidate.
Yu YZ; Gong ZW; Ma Y; Zhang SM; Zhu HQ; Wang WB; Du Y; Wang S; Yu WY; Sun ZW
Vaccine; 2011 Aug; 29(35):5978-85. PubMed ID: 21718736
[TBL] [Abstract][Full Text] [Related]
8. A recombinant live attenuated strain of Vibrio cholerae induces immunity against tetanus toxin and Bordetella pertussis tracheal colonization factor.
Chen I; Finn TM; Yanqing L; Guoming Q; Rappuoli R; Pizza M
Infect Immun; 1998 Apr; 66(4):1648-53. PubMed ID: 9529093
[TBL] [Abstract][Full Text] [Related]
9. [Gene cloning, optimized expression and immunogenicity evaluation of tetanus toxin fragment C].
Wang MY; Zhang YN; Lei M; Zuo DM; Zhang LY; Chen ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 May; 28(5):731-5. PubMed ID: 18504192
[TBL] [Abstract][Full Text] [Related]
10. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
Galen JE; Gomez-Duarte OG; Losonsky GA; Halpern JL; Lauderbaugh CS; Kaintuck S; Reymann MK; Levine MM
Vaccine; 1997; 15(6-7):700-8. PubMed ID: 9178472
[TBL] [Abstract][Full Text] [Related]
11. Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus.
Stratford R; Douce G; Zhang-Barber L; Fairweather N; Eskola J; Dougan G
Vaccine; 2000 Nov; 19(7-8):810-5. PubMed ID: 11115703
[TBL] [Abstract][Full Text] [Related]
12. Factors affecting the immunogenicity of tetanus toxin fragment C expressed in Lactococcus lactis.
Norton PM; Brown HW; Wells JM; Macpherson AM; Wilson PW; Le Page RW
FEMS Immunol Med Microbiol; 1996 Jun; 14(2-3):167-77. PubMed ID: 8809553
[TBL] [Abstract][Full Text] [Related]
13. Comparison of abilities of Salmonella enterica serovar typhimurium aroA aroD and aroA htrA mutants to act as live vectors.
Roberts M; Chatfield S; Pickard D; Li J; Bacon A
Infect Immun; 2000 Oct; 68(10):6041-3. PubMed ID: 10992518
[TBL] [Abstract][Full Text] [Related]
14. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
[TBL] [Abstract][Full Text] [Related]
15. A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice.
Tierney R; Nakai T; Parkins CJ; Caposio P; Fairweather NF; Sesardic D; Jarvis MA
Vaccine; 2012 Apr; 30(20):3047-52. PubMed ID: 22414558
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium.
Dunstan SJ; Simmons CP; Strugnell RA
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):111-9. PubMed ID: 12832114
[TBL] [Abstract][Full Text] [Related]
17. A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC).
Stratford R; Douce G; Bowe F; Dougan G
Vaccine; 2001 Nov; 20(3-4):516-25. PubMed ID: 11672917
[TBL] [Abstract][Full Text] [Related]
18. [Features of expression of the pertussis toxin operon under the control of its own and heterologous promotors in Bordetella bronchiseptica cells].
Govorun VM; Ivanova VF; Kirillov MIu; Klitsunova NV; Nechaeva EV; Siniashina LN; Shumakov IuL; Karataev GI
Mol Gen Mikrobiol Virusol; 1993; (2):21-7. PubMed ID: 8515746
[TBL] [Abstract][Full Text] [Related]
19. Construction of minitransposons for constitutive and inducible expression of pertussis toxin in bvg-negative Bordetella bronchiseptica.
Walker MJ; Rohde M; Wehland J; Timmis KN
Infect Immun; 1991 Nov; 59(11):4238-48. PubMed ID: 1682257
[TBL] [Abstract][Full Text] [Related]
20. DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin.
Anderson RJ; Pasetti MF; Sztein MB; Levine MM; Noriega FR
Vaccine; 2000 Apr; 18(21):2193-202. PubMed ID: 10717338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
